Ketamine tested as Fast-Acting treatment to curb teen suicide risk

This study tested whether ketamine, a medication that can work quickly in adults, could reduce repeat suicidal events in teenagers. It involved 50 teens (ages 13-18) who had recently attempted suicide or had severe suicidal thoughts. Participants received either ketamine or a sedative (midazolam) twice a week for two weeks, while continuing their standard mental health care, and were followed for 12 weeks to see which treatment was better at preventing future suicidal crises.